HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Research and Clinical Trials
Cancer Research and Clinical Trials
- Translational Research: Bridging the gap between laboratory findings and clinical applications.
- Clinical Trial Design: Innovations in trial methodologies and patient recruitment.
- Regulatory Challenges: Navigating the approval process for new therapies.
- Patient Involvement in Research: Ethical considerations and patient advocacy in research.
Cancer research and clinical trials play a crucial role in advancing our understanding of cancer and improving treatment outcomes. Through research, scientists explore the molecular and genetic basis of cancer, enabling the development of targeted therapies that are more effective and less harmful than traditional treatments. Clinical trials are essential for testing new drugs, therapies, and treatment protocols in real-world settings, helping to determine their safety and efficacy. Participants in clinical trials contribute to groundbreaking discoveries that can potentially save lives. As cancer research continues to evolve, it holds promise for finding more personalized treatments and, ultimately, a cure.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Brown University, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Rihab Melliti
Aix en Provence General Hospital, FranceSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Anti-cancer nanomedicine in humans: A review and future directions
Thomas J Webster, Brown University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation